BioEquin F, suspension for injection for horses

Homepage Products Veterinary products BioEquin F, suspension for injection for horses

Active substances in one dose:  

Virus influenzae equorum inactivatum, strains:

A/Equi 2/Limerick 2010 (American type, Florida 1), H3N8      min. 5 log₂ HIT¹

A/Equi 2/Brno 08 (American type, Florida 2), H3N8                min. 5 log₂ HIT¹

1 geometrical average of specific antibodies determinated by heamagglutination inhibition test in serum of guinea pigs

Injection suspension

Target species:

Horse – Equus caballus

Indication:

For the active immunization of horses against equine influenza to reduce clinical signs and excretion of the virus after infection with equine influenza virus.

The onset of immunity was demonstrated by a challenge test for equine influenza strain A/Equi 2/Brno 08 and for equine influenza strain A/Equi 2/Limerick 2010.

The duration of immunity for vaccination strain A/Equi 2/Brno 08 was demonstrated serologically.

Onset of active immunity: 2 weeks after primary vaccination.

Duration of active immunity: 6 months after primary vaccination and 12 months after first revaccination (the third application of vaccine).

Dosage:

1 ml deep intramuscularly.

Primary vaccination course

First injection at the age  6 months, second injection is made 4 weeks later.

Revaccination

The first revaccination (third dose) is given 6 months after the primary vaccination course and further revaccination against influenza is carried out once in 12 months.

Revaccinate pregnant mares in the last trimester of pregnancy, no later than one month before the planned delivery

Shelf life:

33 months, after  the first opening in more doses: 10 hours.

Special storage precaution:

Store in a refrigerator (2 °C – 8 °C)

Package:

2 x 1 dose, 10 x 1 dose.

Not all pack sizes may be marketed.